| Right atrial pressure is not adequate to calculate portal pressure gradient in cirrhosis: a clinical-hemodynamic correlation study. | |
| | |
MedLine Citation:
|
PMID: 20512998 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Hepatic venous pressure gradient (HVPG), the difference between wedge and free hepatic venous pressure, is the preferred method for estimating portal pressure. However, it has been suggested that hepatic atrial pressure gradient (HAPG)--the gradient between wedge hepatic venous pressure and right atrial pressure (RAP)--might better reflect variceal hemodynamics. The aim of this study was to (1) investigate whether HAPG with nonselective beta-blockers correlates with prognosis in cirrhotic patients with portal hypertension at baseline and during treatment; (2) compare the prognostic value of HAPG with that of HVPG; and (3) investigate the agreement between portoatrial gradient (PAG) and portocaval gradient (PCG) in patients with transjugular intrahepatic portosystemic shunt (TIPS). We included 154 cirrhotic patients with varices with a complete hemodynamic study at baseline and on chronic treatment for primary (n = 71) or secondary (n = 83) prophylaxis for bleeding and 99 patients with TIPS. All patients were followed for up to 2 years; portal hypertensive-related bleeding and bleeding-free survival were analyzed. HVPG was equal or lower than HAPG in all patients (-3.2 mm Hg; P < 0.001). Agreement between HAPG and HVPG was modest, especially in patients with increased intra-abdominal pressure. One hundred two patients were HVPG nonresponders and 52 patients were HVPG responders to nonselective beta-blockers, whereas 101 patients were HAPG nonresponders and 53 patients were HAPG responders (k = 0.610). HVPG response revealed an excellent predictive value for bleeding risk and bleeding-free survival; HAPG did not. In our TIPS patients, 20% had a PCG < or =12 mm Hg and a PAG >12 mm Hg, which may have induced unnecessary overdilation of the TIPS. CONCLUSION: The excellent prognostic information provided by HVPG response to drug therapy is lost if HAPG response is considered. RAP should not be used for the calculation of portal pressure gradient in patients with cirrhosis. |
| | |
Authors:
|
Vincenzo La Mura; Juan G Abraldes; Annalisa Berzigotti; Eva Erice; Alexandra Flores-Arroyo; Juan Carlos Garc?a-Pag?n; Jaime Bosch |
Related Documents
:
|
8073508 - Modified simple cold storage of rat livers with uw solution. 2114438 - Nitroglycerin for portal hypertension. a controlled comparison of the hemodynamic effec... 8682148 - Effects of the pringle maneuver on hemodynamics during laparoscopic liver resection in ... 3978998 - Effect of propranolol on hepatic blood flow in patients with cirrhosis. 2534058 - Altered electrical response to caffeine exposure in hypertrophied rat myocardium. 6119558 - Untreated mild hypertension. a report by the management committee of the australian the... |
Publication Detail:
|
Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Hepatology (Baltimore, Md.) Volume: 51 ISSN: 1527-3350 ISO Abbreviation: Hepatology Publication Date: 2010 Jun |
Date Detail:
|
Created Date: 2010-05-31 Completed Date: 2010-06-17 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8302946 Medline TA: Hepatology Country: United States |
Other Details:
|
Languages: eng Pagination: 2108-16 Citation Subset: IM |
Affiliation:
|
Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Cl?nic, Institut d'Investigacions Biom?diques August Pi i Sunyer, University of Barcelona and Centro de Investigaci?n Biom?dica en Red de Enfermedades Hep?ticas y Digestivas (CIBERehd), Barcelona, Spain. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adrenergic beta-Antagonists
/
therapeutic use Adult Aged Blood Pressure Determination Female Hemorrhage / etiology, surgery Humans Hypertension, Portal / diagnosis, drug therapy, mortality, physiopathology* Liver Cirrhosis / complications, physiopathology* Male Middle Aged Portal Pressure* Portasystemic Shunt, Transjugular Intrahepatic Prognosis Retrospective Studies |
| Chemical | |
Reg. No./Substance:
|
0/Adrenergic beta-Antagonists |
| Comments/Corrections | |
Comment In:
|
Hepatology. 2010 Jun;51(6):1894-6
[PMID:
20512984
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Hypertrophic cardiomyopathy and dysregulation of cardiac energetics in a mouse model of biliary fibr...
Next Document: Causality assessment in drug-induced liver injury using a structured expert opinion process: compari...